Protocol Name: Study to Evaluate the Safety, Tolerability, and Effect on Albuminuria of MZE829 in Adults with Proteinuric Chronic Kidney Disease and the APOL1 High Risk Genotype
Protocol #: MZE829-201
Indication:APOL1-Mediated Proteinuric Kidney Disease
GFR: ≥25
Principal Investigator: Tapan J. Patel, MD, FACP, FASN, FNKF
Location: Landry Center, 411 N. Washington Ave, Suite #6000, Dallas, TX 75246